Accelerate Clinical Trials with Our Unified eClinical Platform
Ten purpose-built modules — from EDC and RTSM to RBQM and real-time analytics — designed for regulatory compliance, operational efficiency, and faster time to database lock.
Ten Modules. One Unified Ecosystem.
Every module is purpose-built for clinical research, fully validated, and designed to work together or independently within your existing technology stack.
EDC
Electronic Data Capture
Streamline study builds with CDISC-aligned CRF design, intelligent edit checks, and automated query management for faster database lock.
Learn MoreRTSM / IRT
Randomisation & Trial Supply
Configurable randomisation algorithms, real-time drug supply forecasting, and blinding management with complete audit trails.
Learn MoreCTMS
Clinical Trial Management
Centralised site management, milestone tracking, financial oversight, and operational dashboards for end-to-end study execution.
Learn MoreePRO / eCOA
Patient Reported Outcomes
Validated instruments across mobile, tablet, and web with smart reminders, offline capability, and multi-language support.
Learn MoreeConsent
Digital Informed Consent
Multimedia-rich consent flows with comprehension checks, remote e-signatures, version control, and IRB/EC integration.
Learn MoreDocuVault eTMF
Electronic Trial Master File
DIA reference model structure, automated filing, quality review workflows, completeness dashboards, and inspection-ready exports.
Learn MorerSDV
Remote Source Verification
Secure remote access to source documents, structured verification workflows, and seamless EDC integration for decentralised monitoring.
Learn MoreeClinical Analytics
Intelligence & Reporting
Cross-module dashboards with configurable KRIs, predictive modelling, risk signal detection, and automated regulatory reporting.
Learn MoreAdjudication
Endpoint Adjudication
Committee management, blinded case dossier assembly, consensus voting workflows, and comprehensive adjudication analytics.
Learn MoreRBQM
Risk-Based Quality Management
Centralised monitoring, KRI dashboards, quality tolerance limits, risk signal detection, and ICH E6(R2)/R3 aligned oversight.
Learn MoreStrategic Expertise Across the Clinical Lifecycle
Beyond technology, our domain experts bring decades of hands-on experience in pharmaceutical consulting, regulatory strategy, and clinical operations.
- Regulatory strategy and global submission planning
- Clinical data management and CDISC standards
- Biostatistics and statistical analysis plans
- SAS programming for TLFs and SDTM/ADaM
- Quality assurance and GxP compliance audits
- Pharmacovigilance and safety reporting
- Protocol development and medical writing
Partnering Across the Life Sciences Ecosystem
Pharma & Biotech
Supporting sponsors from early phase through post-marketing with end-to-end clinical technology and consulting services.
Contract Research Organisations
Scalable, multi-sponsor platform infrastructure with rapid study configuration and enterprise-grade SLA support.
Clinical Sites & Hospitals
Intuitive tools that simplify site workflows, reduce administrative burden, and accelerate patient enrolment timelines.
Built for the Demands of Modern Clinical Research
Unified Platform
All nine modules share a common data layer, eliminating silos and enabling cross-functional visibility.
Validated & Compliant
Full IQ/OQ/PQ validation documentation with electronic signatures and comprehensive audit trails.
Cloud-Native Architecture
Secure, scalable multi-tenant infrastructure with 99.8% uptime and SOC 2 Type II certification.
Rapid Deployment
Go live within weeks, not months. Pre-configured templates and guided setup reduce time to first patient.
Latest Regulatory News & Insights
Stay informed with the latest guidance, approvals, and regulatory developments from global health authorities shaping the future of clinical research.
WHO urges governments to protect young people from addiction to tobacco and nicotine products
Worldwide, at least 40 million children aged 13–15 use tobacco products, and young people’s use of e-cigarettes and nicotine pouches continues to rise. I...
Read Full ArticleTwo arrested during the MHRA’s largest ever seizure of unlicensed weight loss medicines
The raid on a Northamptonshire estate dismantled what is believed to be a major illicit manufacturing and distribution operation
Read Full ArticleRilzabrutinib authorised to treat adults with immune thrombocytopenia when prior treatments have been insufficient
As with any medicine, the MHRA will keep the safety and effectiveness of rilzabrutinib under close review.
Read Full ArticleExperts convened by WHO advise on candidate treatments and vaccines for Ebola disease caused by Bundibugyo virus
In response to the current outbreak of Ebola disease caused by Bundibugyo virus occurring in the Democratic Republic of the Congo, with cases also reported i...
Read Full ArticleMessage by the WHO Director-General to the people of the Democratic Republic of the Congo
To the people of DRC, especially to the people of Ituri Jambo kwenu wakahaji wa Ituri Mbote na bino, bato ya Ituri My name is Tedros, and I am...
Read Full ArticleAutomatically updated from official regulatory RSS feeds
Ready to Transform Your Clinical Trials?
Discover how our integrated platform and consulting expertise can streamline your operations and accelerate your path to regulatory approval.